Date Title Description PDF
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download

Pages

Date Title Description PDF
10 Apr 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Download
21 Feb 2023 Annual Corporate Governance Report ROVI releases the 2022 Annual Corporate Governance Report Download
21 Feb 2023 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors Download
16 Feb 2023 On business and financial situation The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States. Download
09 Jan 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the fourth quarter of 2022 Download

Pages

Date Title Description PDF
16 Feb 2017 Información sobre resultados (2) ROVI releases the press release related to the full year 2016 results Download
16 Feb 2017 Información sobre resultados ROVI releases the presentation related to the full year 2016 results Download
16 Feb 2017 Informe Anual de Gobierno Corporativo ROVI releases the 2016 Annual Corporate Governance Report Download
10 Jan 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the fourth quarter of 2016 Download
22 Nov 2016 Acuerdos estratégicos con terceros ROVI announces the marketing agreement of Neparvis in Spain Download

Pages